Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06866132 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Response to an Investigational Device in Patients With Restless Legs Syndrome

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Aug 31, 2025 to Aug 4, 2025
    • Site details revised
    v3
  2. Start date changed from estimate of Mar 10, 2025 to Mar 11, 2025v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
Trial Details
NCT Number NCT06866132
Lead Sponsor Noctrix Health, Inc.
Conditions
(from sponsor)		 Restless Legs Syndrome
Related terms Restless Legs Syndrome
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov